Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 04, 2011 09:08 ET | Source: Acasti Pharma Inc.

Acasti Pharma Announces the Initiation of Phase II Clinical Study of CaPre(R) for the Treatment of Hypertriglyceridemia

LAVAL, Quebec, Oct. 4, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Acasti) (TSX.V:APO), a subsidiary of Neptune Technologies & Bioressources Inc. (Neptune), announces the initiation of the...
September 21, 2011 08:30 ET | Source: Acasti Pharma Inc.

Acasti Pharma to Present at JMP Healthcare Conference

LAVAL, Quebec, Sept. 21, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, announces it will present at the...
September 16, 2011 08:30 ET | Source: Acasti Pharma Inc.

Acasti Pharma Reports on Its Oversubscribed Rights Offering

LAVAL, Quebec, Sept. 16, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc. ("Neptune") subsidiary, reports on its Rights Offering...
August 16, 2011 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Reports First Quarter Results

LAVAL, Quebec, Aug. 16, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti") (TSX.V:APO), a Neptune Technologies & Bioressources Inc's ("Neptune") subsidiary, today report its financial results for...
July 21, 2011 08:00 ET | Source: Acasti Pharma Inc.

Acasti Pharma Inc. to Welcome Dr. Harlan Waksal

LAVAL, Quebec, July 21, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Acasti) (TSX-V:APO), a subsidiary of Neptune Technologies & Bioressources Inc., is pleased to announce the nomination of Harlan...